Home
/ Forbius
/ Competitors

Forbius competitorsClear all

CytomX Therapeutics's top competitors include Rakuten Medical and Bolt Biotherapeutics.

	CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.	Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.	Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
Founding Date	Founding Date 2008	Founding Date 2013	Founding Date 2015
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma therapy	Tags Technology biotech oncology platform therapy
Locations	Locations South San Francisco, US HQ	Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US	Locations Redwood City, US HQ
Employees	Employees 15815% increase	Employees 1662% decrease	Employees 63
Valuation ($)	Valuation ($) 119.4 m	Valuation ($) N/A	Valuation ($) 74.6 m
Twitter followers	Twitter followers 971	Twitter followers N/A	Twitter followers 254
Number of tweets (last 30 days)	Number of tweets (last 30 days) 1	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 4
Alexa Website Rank	Alexa Website Rank 524109	Alexa Website Rank 193411	Alexa Website Rank 385341
Employee Rating	Employee Rating 3.5	Employee Rating 2.1	Employee Rating 5
Financial
Revenue (est.)	Revenue (est.) $100.4m (FY, 2020)	Revenue (est.) N/A	Revenue (est.) $215k (FY, 2019)
Net income	Net income ($32.9m) (FY, 2020)	Net income N/A	Net income ($30.5m) (FY, 2019)
Operating ⚠
Patents (US)	Patents (US) 13 (FY, 2016)	Patents (US) N/A	Patents (US) 1 (FY, 2020)
Funding
Total funding raised	Total funding raised $ 132.4m	Total funding raised $ 451.9m	Total funding raised $ 177.5m